Cardiovascular disease is the primary cause of morbidity and mortality among the diabetic population. Both experimental and clinical evidence suggest that diabetic subjects are …
Aim We tested the hypothesis that dapagliflozin may regress left ventricular hypertrophy (LVH) in people with type 2 diabetes (T2D). Methods and results We randomly assigned 66 …
Guidelines Committee - Journal of hypertension, 2003 - journals.lww.com
2003 European Society of Hypertension–European Society of Ca... : Journal of Hypertension 2003 European Society of Hypertension–European Society of Cardiology …
JA Blumenthal, MA Babyak, A Hinderliter… - Archives of internal …, 2010 - jamanetwork.com
Background Although the DASH (Dietary Approaches to Stop Hypertension) diet has been shown to lower blood pressure (BP) in short-term feeding studies, it has not been shown to …
echocardiogram) may be expected to facilitate the identification of patients with chest pain of an ischemic etiology (angina). In a patient presenting to the emergency department with …
AW Haider, MG Larson, EJ Benjamin, D Levy - Journal of the American …, 1998 - jacc.org
Objectives. This study examined the relations of echocardiographically determined left ventricular (LV) mass and hypertrophy to the risk of sudden death. Background …
BA Vakili, PM Okin, RB Devereux - American heart journal, 2001 - Elsevier
Background To date there has been no comprehensive review of the association between left ventricular hypertrophy (LVH) at baseline and subsequent adverse clinical events …
F Perticone, R Ceravolo, A Pujia, G Ventura… - Circulation, 2001 - Am Heart Assoc
Background—Forearm endothelial dysfunction, characterized by an impaired vasodilating response to acetylcholine (ACh), may be associated with several cardiovascular risk factors …
The question of serum uric acid as an independent risk factor in subjects with essential hypertension remains controversial. For up to 12 years (mean, 4.0) we followed 1720 …